{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:19:35Z","timestamp":1793380775657,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.tube.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T12:48:32Z","timestamp":1540903712000},"page":"231-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"113","author":[{"given":"Erik","family":"Tenland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"R\u00f6nnholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Kalsum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Puthia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-6990","authenticated-orcid":false,"given":"Matthias","family":"M\u00f6rgelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-1099","authenticated-orcid":false,"given":"Mina","family":"Davoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Otrocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3659-8203","authenticated-orcid":false,"given":"Nader","family":"Alaridah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Glegola-Madejska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Stureg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Schmidtchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lerm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5785-5307","authenticated-orcid":false,"given":"Brian D.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3467-1350","authenticated-orcid":false,"given":"Gabriela","family":"Godaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2018.10.008_bib1","unstructured":"WHO. reportGlobal tuberculosis report 2017. http:\/\/wwwwhoint\/tb\/publications\/global_report\/en\/. 2017;World Health Organization."},{"issue":"3","key":"10.1016\/j.tube.2018.10.008_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S2213-2600(15)00063-6","article-title":"Tuberculosis treatment and management\u2013an update on treatment regimens, trials, new drugs, and adjunct therapies","volume":"3","author":"Zumla","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"7331","key":"10.1016\/j.tube.2018.10.008_bib3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature09657","article-title":"The challenge of new drug discovery for tuberculosis","volume":"469","author":"Koul","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tube.2018.10.008_bib4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s12889-015-1933-9","article-title":"Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia","volume":"15","author":"Adane","year":"2015","journal-title":"BMC Publ Health"},{"issue":"1","key":"10.1016\/j.tube.2018.10.008_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(08)70260-3","article-title":"Extensively drug-resistant tuberculosis","volume":"9","author":"Jassal","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"42","key":"10.1016\/j.tube.2018.10.008_bib6","doi-asserted-by":"crossref","first-page":"13087","DOI":"10.1073\/pnas.1514135112","article-title":"Peptidoglycan synthesis in Mycobacterium tuberculosis is organized into networks with varying drug susceptibility","volume":"112","author":"Kieser","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.tube.2018.10.008_bib7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nri1180","article-title":"Defensins: antimicrobial peptides of innate immunity","volume":"3","author":"Ganz","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.tube.2018.10.008_bib8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nchembio.1393","article-title":"Immune modulation by multifaceted cationic host defense (antimicrobial) peptides","volume":"9","author":"Hilchie","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"1","key":"10.1016\/j.tube.2018.10.008_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol Rev"},{"issue":"10","key":"10.1016\/j.tube.2018.10.008_bib10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/cb1001558","article-title":"Describing the mechanism of antimicrobial peptide action with the interfacial activity model","volume":"5","author":"Wimley","year":"2010","journal-title":"ACS Chem Biol"},{"issue":"5","key":"10.1016\/j.tube.2018.10.008_bib11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jac\/47.5.575","article-title":"In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis","volume":"47","author":"Linde","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.tube.2018.10.008_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/iai.64.3.926-932.1996","article-title":"In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis","volume":"64","author":"Miyakawa","year":"1996","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.tube.2018.10.008_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/092986611794578288","article-title":"Anti-tuberculosis activity of alpha-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37","volume":"18","author":"Jiang","year":"2011","journal-title":"Protein Pept Lett"},{"issue":"5","key":"10.1016\/j.tube.2018.10.008_bib14","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1128\/AAC.00175-13","article-title":"Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides","volume":"57","author":"Ramon-Garcia","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.tube.2018.10.008_bib15","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1128\/AAC.00940-15","article-title":"Combined bioinformatic and rational design approach to develop antimicrobial peptides against Mycobacterium tuberculosis","volume":"60","author":"Pearson","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.tube.2018.10.008_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059119","article-title":"Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models","volume":"8","author":"Rivas-Santiago","year":"2013","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.tube.2018.10.008_bib17","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/AAC.04054-14","article-title":"The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo","volume":"59","author":"Gao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"7061","key":"10.1016\/j.tube.2018.10.008_bib18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature04051","article-title":"Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus","volume":"437","author":"Mygind","year":"2005","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.tube.2018.10.008_bib19","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1128\/AAC.00453-11","article-title":"Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus","volume":"55","author":"Xiong","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.tube.2018.10.008_bib20","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1128\/IAI.00936-15","article-title":"LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages","volume":"83","author":"Torres-Juarez","year":"2015","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.tube.2018.10.008_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","article-title":"Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis","volume":"41","author":"Rivas-Santiago","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.tube.2018.10.008_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tube.2014.03.011","article-title":"Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects","volume":"94","author":"Padhi","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"issue":"5","key":"10.1016\/j.tube.2018.10.008_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.biotechadv.2016.05.007","article-title":"Antimicrobial peptides as novel anti-tuberculosis therapeutics","volume":"34","author":"Silva","year":"2016","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.tube.2018.10.008_bib24","unstructured":"Sandvang D, Mygind PH, Jones ME, Sahm DF, Kristensen H. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007:F1-F1663."},{"issue":"7","key":"10.1016\/j.tube.2018.10.008_bib25","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1128\/AAC.01584-08","article-title":"In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model","volume":"53","author":"Andes","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.tube.2018.10.008_bib26","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/IAI.67.9.4586-4593.1999","article-title":"Assessment of immunity to mycobacterial infection with luciferase reporter constructs","volume":"67","author":"Snewin","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.tube.2018.10.008_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2012.06.010","article-title":"Efferocytosis is an innate antibacterial mechanism","volume":"12","author":"Martin","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.tube.2018.10.008_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2014.08.021","article-title":"Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10","volume":"21","author":"Sturegard","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tube.2018.10.008_bib29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fcimb.2017.00278","article-title":"The cording phenotype of Mycobacterium tuberculosis induces the formation of extracellular traps in human macrophages","volume":"7","author":"Kalsum","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"10.1016\/j.tube.2018.10.008_bib30","doi-asserted-by":"crossref","first-page":"e112426","DOI":"10.1371\/journal.pone.0112426","article-title":"Replication rates of Mycobacterium tuberculosis in human macrophages do not correlate with mycobacterial antibiotic susceptibility","volume":"9","author":"Raffetseder","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.tube.2018.10.008_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2567.2008.03004.x","article-title":"Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model","volume":"128","author":"Marquina-Castillo","year":"2009","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.tube.2018.10.008_bib32","doi-asserted-by":"crossref","first-page":"e1004619","DOI":"10.1371\/journal.ppat.1004619","article-title":"A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles","volume":"11","author":"Stahl","year":"2015","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.tube.2018.10.008_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ilar.43.4.244","article-title":"Guidelines for the design and statistical analysis of experiments using laboratory animals","volume":"43","author":"Festing","year":"2002","journal-title":"ILAR J"},{"issue":"5","key":"10.1016\/j.tube.2018.10.008_bib34","doi-asserted-by":"crossref","first-page":"L873","DOI":"10.1152\/ajplung.00238.2017","article-title":"Use of proper statistical techniques for research studies with small samples","volume":"313","author":"Morgan","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.tube.2018.10.008_bib35","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/jac\/dku570","article-title":"Natural antimicrobial peptides against Mycobacterium tuberculosis","volume":"70","author":"Abedinzadeh","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2018.10.008_bib36","unstructured":"Assays for predicting acute toxicity. Application of modern toxicology approaches for predicting acute toxicity for chemical defense: National Academies Press (US); 2015."},{"key":"10.1016\/j.tube.2018.10.008_bib37","unstructured":"WHO. Treatment of tuberculosis - guidelines http:\/\/apps.who.int\/iris\/bitstream\/10665\/44165\/1\/9789241547833_eng.pdf2009 [fourth ed.]."},{"key":"10.1016\/j.tube.2018.10.008_bib38","unstructured":"Ekwall B, Silano V, Paganuzzi-Stammati A, Zucc F. Toxicity tests with mammalian cell cultures. Short-term toxicity tests for non-genotoxic effects: John Wiley & Sons Ltd; 1990. p. 75-93."},{"issue":"37","key":"10.1016\/j.tube.2018.10.008_bib39","doi-asserted-by":"crossref","first-page":"15001","DOI":"10.1073\/pnas.1203636109","article-title":"Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide","volume":"109","author":"Grosset","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.tube.2018.10.008_bib40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm0307-282","article-title":"The survival kit of Mycobacterium tuberculosis","volume":"13","author":"Warner","year":"2007","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.tube.2018.10.008_bib41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tube.2006.12.001","article-title":"Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein","volume":"87","author":"Hartkoorn","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"10.1016\/j.tube.2018.10.008_bib42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41598-017-00529-6","article-title":"Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration","volume":"7","author":"Aljayyoussi","year":"2017","journal-title":"Sci Rep"},{"issue":"26","key":"10.1016\/j.tube.2018.10.008_bib43","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1039\/C6OB01002D","article-title":"pH-Dependent membrane lysis by using melittin-inspired designed peptides","volume":"14","author":"Kashiwada","year":"2016","journal-title":"Org Biomol Chem"},{"issue":"5982","key":"10.1016\/j.tube.2018.10.008_bib44","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1185723","article-title":"Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II","volume":"328","author":"Schneider","year":"2010","journal-title":"Science"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979218303470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979218303470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T08:26:49Z","timestamp":1717316809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979218303470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":44,"alternative-id":["S1472979218303470"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2018.10.008","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}